65B-21037-50170
3 vaccinations
7 coded responses
25 check-ins
7 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 342 / FL
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fever · Muscle or body aches, NauseaAdult check-in
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Chills, Headache, Muscle or body achesAdult check-in
- 2020-12-31
- 2021-01-01
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Fatigue or tirednessAdult check-in
- 2021-01-03
-
2021-01-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-06
- 2021-01-12
-
2021-01-19
Survey response — day 21, dose 1MedDRA: Balance disorder, Burning sensation, Paraesthesia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Imbalance, paresthesia of the upper and lower extremities, positive Roomberg. Lasted 4 days. There was a burning feeling on both lateral aspects of the upper limbsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-02-09
Survey response — day 14, dose 2MedDRA: Paraesthesia — Feeling: GoodFree text: Paresthesias that are resolvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-23
- 2021-04-21
- 2021-07-21
-
2021-09-18
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — day 7, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
- 2021-10-02
- 2021-10-09
- 2021-10-16
-
2021-11-01
Survey response — day 42, dose 3MedDRA: Headache, Malaise, Pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, headache, malaise, body achesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-18
Survey response — 3 months, dose 3MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: Mild URI, Covid test was negativeMedDRA releases: 2024-11 · check-in free text available
-
2022-03-19
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive COVID 3/15/2022MedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Survey response — 12 months, dose 3MedDRA: COVID-19, Chest pain, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chest pain, increased fatigue. I had a negative CT coronary angiogram. Fatigue is attributed to COVID acquired in March 2022MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-09-18 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 2 — day 21, dose 1
Symptoms: Imbalance, paresthesia of the upper and lower extremities, positive Roomberg. Lasted 4 days. There was a burning feeling on both lateral aspects of the upper limbs
Release 3 — day 14, dose 2
Symptoms: Paresthesias that are resolving
Release 9 — day 7, dose 3
Systemic reaction (other): None
Release 10 — day 42, dose 3
Symptoms: Congestion, headache, malaise, body aches
Release 10 — 3 months, dose 3
Symptoms: Mild URI, Covid test was negative
Release 11 — 6 months, dose 3
Symptoms: Positive COVID 3/15/2022
Release 12 — 12 months, dose 3
Symptoms: Chest pain, increased fatigue. I had a negative CT coronary angiogram. Fatigue is attributed to COVID acquired in March 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Balance disorder | ✓ | ✓ | ✓ |
| SD | Burning sensation | ✓ | ✓ | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release